Melissa Angst possesses extensive experience in clinical trial operations, having held key leadership roles at prominent pharmaceutical companies. At Pfizer, from June 2019 to February 2022, Melissa served as Director of Regional Clinical Trial Operations and Associate Director for Site Intelligence Lead-Feasibility. Following this, Melissa transitioned to Seagen as Director of Regional Clinical Trial Operations from March 2022 to January 2024. Prior experience includes serving as Operational Intelligence Leader at Hoffmann-La Roche, where consultation to Therapeutic Area Heads and study teams focused on patient recruitment and retention strategies. Additionally, experience at Genentech involved developing patient recruitment strategies, vendor management, and database coordination. Melissa holds a Clinical Trial Management Certificate from the University of California, Berkeley and a Bachelor's Degree in Social Sciences from Ashford University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices